19 USD
+0.04 (+0.21%)
19 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 70% to ICPT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 19.38. This target is 2% above the current price.
ICPT was analyzed by 20 analysts. The buy percentage consensus is at 70. So analysts seem to be have mildly positive about ICPT.
In the previous month the buy percentage consensus was at a similar level.
ICPT was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-09-27 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2023-09-27 | B. Riley Securities | Downgrade | Buy -> Neutral |
| 2023-09-27 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2023-09-27 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-08-03 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2023-08-03 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-07-13 | HC Wainwright & Co. | Upgrade | Sell -> Buy |
| 2023-06-29 | Canaccord Genuity | Upgrade | Hold -> Buy |
| 2023-06-26 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2023-06-15 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2023-05-30 | B. Riley Securities | Maintains | Buy -> Buy |
| 2023-05-23 | Needham | Downgrade | Buy -> Hold |
| 2023-05-23 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2023-05-23 | B of A Securities | Maintains | Underperform -> Underperform |
| 2023-05-22 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2023-05-22 | Baird | Maintains | Outperform -> Outperform |
| 2023-05-22 | HC Wainwright & Co. | Downgrade | Neutral -> Sell |
| 2023-05-18 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2023-04-28 | Raymond James | Maintains | Outperform |
| 2023-04-10 | Piper Sandler | Maintains | Overweight |
| 2023-03-06 | Raymond James | Maintains | Outperform |
| 2023-03-03 | Needham | Maintains | Buy |
| 2023-03-03 | RBC Capital | Maintains | Sector Perform |
| 2023-03-03 | SVB Leerink | Maintains | Market Perform |
| 2023-02-15 | RBC Capital | Maintains | Sector Perform |
| 2023-01-20 | Raymond James | Maintains | Outperform |
| 2022-11-16 | HC Wainwright & Co. | Maintains | Neutral |
| 2022-11-02 | Raymond James | Maintains | Outperform |
| 2022-10-03 | SVB Leerink | Maintains | Market Perform |
| 2022-10-03 | Baird | Maintains | Outperform |
INTERCEPT PHARMACEUTICALS IN / ICPT FAQ
What is the average price target for INTERCEPT PHARMACEUTICALS IN (ICPT) stock?
20 analysts have analysed ICPT and the average price target is 19.38 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 19.
Can you provide the consensus rating for INTERCEPT PHARMACEUTICALS IN stock?
The consensus rating for INTERCEPT PHARMACEUTICALS IN (ICPT) is 70 / 100 . This indicates that analysts generally have a neutral outlook on the stock.